Valo Ventures said it raised a $175 million first venture-capital fund to invest in companies using digital and cloud technologies to address social, economic, and environmental challenges and trends.
BrightPlan said it raised a $12 million Series B round from existing investors in May.
The following story is part of a cover package VCJ published in its June issue about how the latest developments in gene editing and gene therapy are triggering new wave of investments. Read the main story here: Gene editing rides new investment wave. Read here about the moral implications to consider: Ethical concerns dog gene editing. […]
Ascend Ventures has set out to raise an initial venture-capital fund, according to a filling with the SEC.
Venture capital returns fell in the fourth quarter of last year, taking a cue from the tumbling financial markets as worries over the trade war with China spooked stock buyers. The public markets were also at the time digesting rates hikes from the Federal Reserve. One-quarter returns for U.S. funds slumped to a 1.71 percent […]
The other big loser at the Golden State Warriors game Wednesday night – the “Dubs” lost badly to the Toronto Raptors, which took a 2-1 game lead in the Championship Finals – was former Sequoia Capital investor Mark Stevens. Stevens was ejected from the game and drew a ban and a fine from the National […]
The following story is part of a cover package VCJ published in its June issue about a new wave of investments related to gene editing and the moral implications investors must consider. Read the main story here: Gene editing rides new investment wave. —Ed. In late April, GV Venture Partner Anthony Philippakis joined more than 60 academics and […]
Rx3 Ventures, a firm co-founded by Green Bay Packers quarterback Aaron Rodgers, launched on Wednesday with $50 million of capital to back consumer companies with growth rounds. Rogers, who has played with the Packers for more than a decade, will serve as general partner at the Newport Beach, California-based outfit, along with Nate Raabe and […]
Jazz Venture Partners has raised a $287 million venture-capital fund focused on companies improving human performance, according to a filing with the SEC.
Patamar Capital has raised $23.6 million toward a $150 million venture-capital fund, according to a filing with the SEC.
Northgate Capital has set out to raise a $120 million venture-capital fund, according to a filing with the SEC.
Clinical approvals are lifting confidence in gene editing and gene therapy, triggering a new wave of investment. Could this be healthcare’s new new thing?
MetaProp has set out to raise a $100 million third investment fund, according to a filing with the SEC.
Santé Ventures said it raised a $250 million third fund that is 79 percent larger than its second fund and aimed at maintaining ownership levels in its most successful portfolio companies. The life sciences fund will target investments in 20 to 25 companies, was oversubscribed by 25 percent, and attracted more than 30 LPs. Among […]
Sovereign wealth funds continued to pour money into private technology companies last year, accelerating a multi-year shift away from public markets as investment opportunities in private startups turned more exciting. These well-heeled investors steered $3.4 billion into 44 direct private technology deals worldwide in 2018, an almost 2.5x increase in capital over 2017, according to […]
The Riverside Company has raised $29.4 million toward a $50 million second opportunity fund, according to a filing with the SEC.
Jim Breyer will leave the Harvard Corp. at the end of June after six years of service, according to a report in The Harvard Gazette.
MaC Venture Capital has set out to raise a $100 million venture-capital fund, according to a filing with the SEC.